Approximately 25% of ALK- ALCL expresses an oncogenic truncated ERB-B2 receptor tyrosine kinase-4 (ERBB4) that is not detected in ALK+ ALCL and PTCL-NOS and may likely form another subgroup of ALK- ALCL. The gene discussed is ERBB4; the disease is anaplastic large cell lymphoma.